Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and Topiramate in Traumatic Cerebrospinal Fluid Leakage
IRCT20221108056446N4Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetazolamide and topiramate in cerebrospinal fluid leak and traumatic brain injury (TBI), sponsored by Isfahan University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
acetazolamidetopiramate
03
Conditions
cerebrospinal fluid leaktraumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20221108056446N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056446N4.